erlotinib hydrochloride has been researched along with Hypertrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davisson, RL; Eguchi, S; Elliott, KJ; Forrester, SJ; Fukuda, Y; Kawai, T; Obama, T; Park, JY; Takayanagi, T; Tilley, DG; Tsuji, T | 1 |
Ding, W; Gu, Y; Niu, J; Qiao, Z; Sheng, L; Yang, M; Zhang, M | 1 |
2 other study(ies) available for erlotinib hydrochloride and Hypertrophy
Article | Year |
---|---|
Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Disease Models, Animal; Endoplasmic Reticulum Stress; Endothelium, Vascular; ErbB Receptors; Erlotinib Hydrochloride; Hypertension; Hypertrophy; Mice; Muscle, Smooth, Vascular; Phenylbutyrates; Quinazolines; Random Allocation; Role; Sensitivity and Specificity; Signal Transduction; Vascular Remodeling | 2015 |
Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney.
Topics: Aldosterone; Animals; Cell Line; Cell Movement; Cell Proliferation; ErbB Receptors; Erlotinib Hydrochloride; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Hypertrophy; Kidney; Kidney Glomerulus; Male; MAP Kinase Signaling System; Mesangial Cells; Mice; Models, Biological; Phosphorylation; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Mineralocorticoid; Signal Transduction; Transcriptional Activation | 2016 |